Thrombotic thrombocytopenic purpura (TTP)
Showing 26 - 50 of 1,226
Acquired Thrombotic Thrombocytopenic Purpura Trial in Shanghai (Anfibatide, Placebos)
Unknown status
- Acquired Thrombotic Thrombocytopenic Purpura
- Anfibatide
- Placebos
-
Shanghai, Shanghai, ChinaShanghai Ruijing Hospital
Jul 15, 2019
MATRIX "Renal and Systemic Thrombotic Microangiopathy"
Recruiting
- Thrombotic Microangiopathy
- +4 more
- Collecting datas
-
Tours, FranceDepartment of Nephrology, University Hospital of Tours
Aug 10, 2023
Efficiency of Caplacizumab in the Treatment of aTTP
Recruiting
- Acquired Thrombotic Thrombocytopenic Purpura
-
Cologne, GermanyUniversity Hospital of Cologne
Dec 28, 2021
Thrombotic Thrombocytopenic Purpura, Acquired Trial (Caplacizumab)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura, Acquired
- (no location specified)
Jan 19, 2021
Octaplas Adult TTP Trial
Terminated
- Thrombotic Thrombocytopenic Purpura
- Octaplas
- Standard Plasma
-
Manhasset, New York
- +1 more
Oct 10, 2019
The Role of Microparticles as a Biomarker
Withdrawn
- Atypical Hemolytic Uremic Syndrome
- +3 more
-
Rochester, New YorkUniversity of Rochester Medical Center
Feb 15, 2019
Thrombotic Thrombocytopenic Purpura Trial in New York (Danazol)
Terminated
- Thrombotic Thrombocytopenic Purpura
-
New York, New YorkMount Sinai St. Luke's-Roosevelt
Dec 6, 2018
The United Kingdom Thrombotic Thrombocytopenic Purpura Registry
Recruiting
- TTP - Thrombotic Thrombocytopenic Purpura
- ADAMTS13, VWF assay
-
London, United KingdomUniversity College London Hospital
Feb 5, 2019
Immune Thrombocytopenia, Thrombotic Thrombocytopenic Purpura Trial in Monterrey (Romiplostim, Rituximab, Dexamethasone)
Unknown status
- Immune Thrombocytopenia
- Thrombotic Thrombocytopenic Purpura
- Romiplostim
- +2 more
-
Monterrey, Nuevo León, MexicoServicio de Hematología, Hospital Universitario "Dr. José Eleute
Oct 8, 2020
Idiopathic Thrombocytopenic Purpura Trial in Russian Federation (GNR-069)
Enrolling by invitation
- Idiopathic Thrombocytopenic Purpura
- GNR-069
-
Irkutsk, Irkutsk Region, Russian Federation
- +12 more
Aug 5, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta, Ann Arbor, Saint Louis (Dexamethasone, Ixazomib,
Active, not recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Dexamethasone
- +2 more
-
Atlanta, Georgia
- +3 more
Jan 6, 2023
Thrombotic Microangiopathies, Hematologic Diseases Trial in Suzhou (N-Acetylcysteine, Placebo Oral Tablet)
Completed
- Thrombotic Microangiopathies
- Hematologic Diseases
- N-Acetylcysteine
- Placebo Oral Tablet
-
Suzhou, Jiangsu, ChinaThe First affiliated Hospital of SooChow University
Jan 19, 2022
Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura
Not yet recruiting
- ITP - Immune Thrombocytopenia
- eltrombopag and romiplastim
- (no location specified)
Nov 16, 2023
TTP and aHUS in Complicated Pregnancies
Unknown status
- Thrombotic Thrombocytopenic Purpura
- +7 more
- ADAMTS 13, complement and angiogenic biomarkers
-
London, United KingdomUniversity College London Hospital
Sep 21, 2018
Idiopathic Thrombocytopenic Purpura Trial (Placebo, AMG 531)
Completed
- Idiopathic Thrombocytopenic Purpura
- Placebo
- AMG 531
- (no location specified)
Nov 4, 2022
Thrombotic Disorder Trial (N-acetyl-cysteine, Busulfan, Cytarabine)
Not yet recruiting
- Thrombotic Disorder
- N-acetyl-cysteine
- +3 more
- (no location specified)
Jun 8, 2023
Septic Shock Trial in Calgary (Therapeutic plasma exchange)
Recruiting
- Septic Shock
- Therapeutic plasma exchange
-
Calgary, Alberta, Canada
- +1 more
Feb 15, 2022
COVID-19 Vaccine and Development of Immune Thrombocytopenic
Recruiting
- COVID-19 Vaccine
- covid19 vaccines
-
Assiut, EgyptEgypt
Jul 12, 2022
Idiopathic Thrombocytopenic Purpura Trial in Russian Federation (GNR-069, Nplate)
Recruiting
- Idiopathic Thrombocytopenic Purpura
- GNR-069
- Nplate
-
Irkutsk, Irkutsk Region, Russian Federation
- +17 more
Aug 3, 2022
Pediatric Primary Immune Thrombocytopenia (ITP)
Recruiting
- Primary Immune Thrombocytopenia
- data collection
-
Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Oct 31, 2023
Thrombotic Microangiopathies, Thrombotic Thrombocytopenic Purpura Trial in Paris (Biological and imaging investigations)
Completed
- Thrombotic Microangiopathies
- Thrombotic Thrombocytopenic Purpura
- Biological and imaging investigations
-
Paris, FranceSaint Antoine
Jul 23, 2019
Kidney Cancer Metastatic, Kidney Cancer, Kidney Cancer, Stage IV Trial in Baltimore, Dallas (Nivolumab/Ipilimumab, SBRT)
Completed
- Kidney Cancer Metastatic
- +2 more
- Nivolumab/Ipilimumab
- SBRT
-
Baltimore, Maryland
- +1 more
Mar 29, 2021
Idiopathic Thrombocytopenic Purpura Trial in Multiple Locations (R788, Placebo)
Active, not recruiting
- Idiopathic Thrombocytopenic Purpura
- R788
- Placebo
-
Multiple Locations, JapanResearch Site
Mar 22, 2022